Abstract

Hepatitis B virus (HBV) co-infection with human immunodeficiency virus is a major public health problem especially in developing countries. In this study, the prevalence of HBV infection was evaluated among 400 consenting HIV patients accessing healthcare in Federal Medical Center, Keffi, Nigeria using HBsAg detection as the surrogate. Blood samples were collected and screened for HBsAg using ACON screening kit (ACON Laboratories Inc, USA). The Chi-square statistical test was performed to identify possible determining factors associated with the viral infection. Overall, 30 (7.5%) of the participants were reactive to HBsAg. The possible determining factors for acquiring the virus recorded in this study were marital status and alcoholism (p0.05). This finding calls for a concern because co-infection of HBV with HIV accelerates disease progression and also has an effect on the management of patients infected with HIV.

Highlights

  • Hepatitis is caused by different agents such as heavy alcohol use, nonalcoholic steatohepatitis (NASH), certain medication, toxins, other infections, and autoimmune diseases

  • Compared with individuals that are only infected with Hepatitis B virus (HBV), the course of chronic HBV infection in HIV co-infected patients is more aggressive resulting in lower transaminase elevation, increased HBV DNA levels, decreased inflammatory activity and a higher prevalence of cirrhosis and hepatocellular carcinoma [3]

  • A total of 400 HIV seropositive patients accessing Antiretroviral Therapy (ART) in Federal Medical Centre, Keffi participated in the study

Read more

Summary

Introduction

Hepatitis is caused by different agents such as heavy alcohol use, nonalcoholic steatohepatitis (NASH), certain medication, toxins, other infections, and autoimmune diseases. There are several reports of HBV/HIV co-infection in Nigeria [6, 7, 8], for any control research work to be successful there is need for adequate information on the epidemiology of the disease including the population at risk. Considering this context, the present study was aimed to investigate the prevalence and determinants of hepatitis b virus among human immunodeficiency virus patients at a tertiary health care facility in Central Nigeria. Alaku et al / World Journal of Advanced Research and Reviews, 2020, 06(02), 227–233

Study area and population
Results and discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call